Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus

Wen Nan Huang, Tim K. Tso, Hui Yu Huang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis, and an increased susceptibility of plasma lipids and lipoproteins to oxidation could at least in part promote atherogenesis. The objective of this study was to identify the effects of anticardiolipin antibody (aCL) and disease activity on oxidative and antioxidative status in patients with SLE. In this study, patients in SLE/aCL+ group and in SLE disease activity index >3 group had significantly higher thiobarbituric acid reactive substance (TBARS) levels, titers of autoantibodies against oxidized low-density lipoprotein (ox-LDL), and glutathione peroxidase activity than that of healthy controls. However, only TBARS and titers of autoantibodies against ox-LDL but not antioxidant enzyme activities were significantly different between SLE subgroups. Thus, enhanced oxidative status but not corresponding elevated antioxidative status by the presence of aCL and active disease activity make potent antioxidant therapy valuable for these SLE patients in preventing oxidative damage.

Original languageEnglish
Pages (from-to)453-458
Number of pages6
JournalRheumatology International
Volume27
Issue number5
DOIs
Publication statusPublished - Mar 1 2007
Externally publishedYes

Fingerprint

Anticardiolipin Antibodies
Systemic Lupus Erythematosus
Thiobarbituric Acid Reactive Substances
Autoantibodies
Atherosclerosis
Antioxidants
Glutathione Peroxidase
Lipoproteins
Lipids
Enzymes

Keywords

  • Anticardiolipin
  • Antioxidant enzyme
  • Lipoprotein oxidation
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

@article{bf04a057d9c04f6b960efaeddce13f3d,
title = "Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus",
abstract = "Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis, and an increased susceptibility of plasma lipids and lipoproteins to oxidation could at least in part promote atherogenesis. The objective of this study was to identify the effects of anticardiolipin antibody (aCL) and disease activity on oxidative and antioxidative status in patients with SLE. In this study, patients in SLE/aCL+ group and in SLE disease activity index >3 group had significantly higher thiobarbituric acid reactive substance (TBARS) levels, titers of autoantibodies against oxidized low-density lipoprotein (ox-LDL), and glutathione peroxidase activity than that of healthy controls. However, only TBARS and titers of autoantibodies against ox-LDL but not antioxidant enzyme activities were significantly different between SLE subgroups. Thus, enhanced oxidative status but not corresponding elevated antioxidative status by the presence of aCL and active disease activity make potent antioxidant therapy valuable for these SLE patients in preventing oxidative damage.",
keywords = "Anticardiolipin, Antioxidant enzyme, Lipoprotein oxidation, Systemic lupus erythematosus",
author = "Huang, {Wen Nan} and Tso, {Tim K.} and Huang, {Hui Yu}",
year = "2007",
month = "3",
day = "1",
doi = "10.1007/s00296-006-0233-1",
language = "English",
volume = "27",
pages = "453--458",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus

AU - Huang, Wen Nan

AU - Tso, Tim K.

AU - Huang, Hui Yu

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis, and an increased susceptibility of plasma lipids and lipoproteins to oxidation could at least in part promote atherogenesis. The objective of this study was to identify the effects of anticardiolipin antibody (aCL) and disease activity on oxidative and antioxidative status in patients with SLE. In this study, patients in SLE/aCL+ group and in SLE disease activity index >3 group had significantly higher thiobarbituric acid reactive substance (TBARS) levels, titers of autoantibodies against oxidized low-density lipoprotein (ox-LDL), and glutathione peroxidase activity than that of healthy controls. However, only TBARS and titers of autoantibodies against ox-LDL but not antioxidant enzyme activities were significantly different between SLE subgroups. Thus, enhanced oxidative status but not corresponding elevated antioxidative status by the presence of aCL and active disease activity make potent antioxidant therapy valuable for these SLE patients in preventing oxidative damage.

AB - Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis, and an increased susceptibility of plasma lipids and lipoproteins to oxidation could at least in part promote atherogenesis. The objective of this study was to identify the effects of anticardiolipin antibody (aCL) and disease activity on oxidative and antioxidative status in patients with SLE. In this study, patients in SLE/aCL+ group and in SLE disease activity index >3 group had significantly higher thiobarbituric acid reactive substance (TBARS) levels, titers of autoantibodies against oxidized low-density lipoprotein (ox-LDL), and glutathione peroxidase activity than that of healthy controls. However, only TBARS and titers of autoantibodies against ox-LDL but not antioxidant enzyme activities were significantly different between SLE subgroups. Thus, enhanced oxidative status but not corresponding elevated antioxidative status by the presence of aCL and active disease activity make potent antioxidant therapy valuable for these SLE patients in preventing oxidative damage.

KW - Anticardiolipin

KW - Antioxidant enzyme

KW - Lipoprotein oxidation

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=33847094136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847094136&partnerID=8YFLogxK

U2 - 10.1007/s00296-006-0233-1

DO - 10.1007/s00296-006-0233-1

M3 - Article

C2 - 17028858

AN - SCOPUS:33847094136

VL - 27

SP - 453

EP - 458

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 5

ER -